Ichnos Glenmark Innovation Appoints Lida Pacaud as Interim Chief Executive Officer
Position
Chief Executive Officer
Company
Ichnos Glenmark Innovation
New YorkBiotechnologyHealth CareTherapeuticsBiopharmaDescription
Ichnos Glenmark Innovation, Inc has appointed Lida Pacaud, MD, as Interim Chief Executive Officer, succeeding Cyril Konto, MD. Dr Pacaud is an accomplished physician with a strong track record in oncology drug development.
Quick answer
Ichnos Glenmark Innovation Appoints Lida Pacaud as Interim Chief Executive Officer (December 4, 2025). Ichnos Glenmark Innovation is based in New York, New York, United States.
- Who is the new Chief Executive Officer at Ichnos Glenmark Innovation?
- Ichnos Glenmark Innovation named Lida Pacaud Chief Executive Officer, announced December 4, 2025.
- What did Ichnos Glenmark Innovation announce on December 4, 2025?
- Ichnos Glenmark Innovation, Inc has appointed Lida Pacaud, MD, as Interim Chief Executive Officer, succeeding Cyril Konto, MD. Dr Pacaud is an accomplished physician with a strong track record in oncology drug development.
- What does Ichnos Glenmark Innovation do?
- Ichnos Glenmark Innovation (IGI) is a global, fully integrated clinical-stage biotechnology company focused on developing innovative biologics in oncology.
- Where is Ichnos Glenmark Innovation based?
- Ichnos Glenmark Innovation is based in New York, New York, United States.
- Which similar companies made leadership changes around the same time?
- Sudo Biosciences (December 4, 2025), Jubilant Therapeutics (December 2, 2025), VistaGen (December 1, 2025) and Expression Therapeutics (December 10, 2025) also announced leadership changes within 45 days of Ichnos Glenmark Innovation.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biopharma
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Sudo Biosciences Appoints Paul Bavier as Chief Legal Officer (December 4, 2025)
- Jubilant Pharmova Appoints Daniel J. O’Connor as Chief Executive Officer (December 2, 2025)
- Vistagen Appoints Nick Tressler as Chief Financial Officer (December 1, 2025)
- Expression Therapeutics Appoints David F. Townson as Chief Executive Officer (December 10, 2025)
- Centessa Pharmaceuticals Appoints Mario Alberto Accardi as CEO (December 12, 2025)
- Gilead Sciences Appoints Keeley Wettan as Executive Vice President, General Counsel (December 18, 2025)
Who to call at Ichnos Glenmark Innovation, and when
A new leader at Ichnos Glenmark Innovation brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Ichnos Glenmark Innovation raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Ichnos Glenmark Innovation, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Ichnos Glenmark Innovation. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Ichnos Glenmark Innovation changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Ichnos Glenmark Innovation changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.